This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pulmonary Arterial Hypertension
and you are
over 18
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

In this prospective study, the investigators will implement a systematic screening program and 3-year follow-up in a cohort of asymptomatic BMPR2 mutation carriers. This study is designed to: - determine predictive factors (biological, functional, radiological and hemodynamic) of development of PAH - monitor these subjects' clinical, functional, biological, echocardiographic and hemodynamic characteristics - assess the risk of occurrence of PAH - screen patients with PAH at an early stage of disease and offer them an early management - constitute a collection of biological samples (0, 12, 24 months follow-up) of asymptomatic BMPR2 mutation carriers.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01600898. The sponsor of the trial is Assistance Publique - Hôpitaux de Paris and it is looking for 55 volunteers for the current phase.
Official trial title:
Screening and Risk Factors of Pulmonary Arterial Hypertension in BMPR2 Mutation Asymptomatic Carriers